查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
亞太地區器官移植診斷市場：分析與預測（2023-2033）
市場調查報告書
商品編碼
1439029

亞太地區器官移植診斷市場：分析與預測（2023-2033）

Asia-Pacific Organ Transplant Diagnostics Market: Analysis and Forecast, 2023-2033
出版日期: | 出版商: BIS Research | 英文 71 Pages | 商品交期: 1-5個工作天內

價格
主要市場統計數據
預測期 2023-2033
2023年評估價值 12.5億美元
2033年預測 34.5億美元
複合年成長率 10.73%

2023年亞太地區器官移植診斷市場規模達12.5億美元。

預計到 2033 年，市場規模將達到 34.5 億美元，2023-2033 年預測期間複合年成長率為 10.73%。導致器官衰竭的慢性疾病增加，移植診斷的使用擴大，幹細胞療法的採用擴大，由於白血病患者數量的增加對移植診斷測試的需求增加，移植領域分子和基因組技術的進步帶來的好處診斷和報銷系統許多關鍵因素正在推動該行業的發展，包括有利的法規環境的存在。

在多種因素的推動下，亞太地區器官移植診斷市場正在經歷顯著成長。這包括導致器官衰竭的慢性疾病盛行率增加、移植診斷的使用增加以及該地區對幹細胞治療的接受度增加。此外，白血病等疾病的日益普及正在推動對移植診斷測試的需求。該領域也受益於提高診斷能力的分子和基因組技術的進步。此外，報銷計劃等有利的監管條件進一步刺激了市場成長。為了滿足器官移植有效診斷解決方案日益成長的需求，亞太地區器官移植診斷市場將顯著擴張。

本報告探討了亞太地區器官移植診斷市場，概述了市場、國家趨勢以及進入市場的公司概況。

目錄

執行摘要

第1章 市場範圍

第2章調查方法

第3章器官移植診斷市場：概述

  • 目前的市場狀況
  • 市場足跡
  • COVID-19 對市場的影響

第4章器官移植診斷市場：產業分析

  • 概述
  • 亞太地區的法律要求與框架
    • 中國
    • 日本
  • 贖回場景
  • 專利分析

第5章器官移植診斷市場：市場動態

  • 影響分析
  • 市場驅動力
  • 市場限制
  • 市場機會

第6章 區域

  • 亞太地區
    • 亞太地區器官移植試驗數量（依移植類型）
    • 市場規模及預測

第7章 公司簡介

Product Code: BHP1874SS

The Asia-Pacific Organ Transplant Diagnostics Market Expected to Reach $3.45 Billion by 2033

Introduction to Asia-Pacific Organ Transplant Diagnostics Market

KEY MARKET STATISTICS
Forecast Period2023 - 2033
2023 Evaluation$1.25 Billion
2033 Forecast$3.45 Billion
CAGR10.73%

In 2023, the Asia-Pacific organ transplant diagnostics market was valued at $1.25 billion and is expected to reach $3.45 billion by 2033, with a CAGR of 10.73% during the forecast period 2023-2033. Numerous pivotal factors are driving growth in this industry, comprising a rise in chronic diseases leading to organ failure, increased utilization of transplant diagnostics, growing adoption of stem cell therapy, heightened demand for transplant diagnostic tests due to an uptick in leukemia cases, advantages stemming from advancements in molecular and genomic technologies in the transplant diagnostics realm, and the presence of favorable regulatory environments, including reimbursement schemes.

Market Introduction

The Asia-Pacific (APAC) organ transplant diagnostics market is experiencing significant growth, propelled by various factors. This includes the escalating incidence of chronic diseases leading to organ failure, the expanding utilization of transplant diagnostics, and a rising acceptance of stem cell therapy in the region. Additionally, the increasing prevalence of conditions like leukemia is driving demand for transplant diagnostic tests. The sector also benefits from advancements in molecular and genomic technologies, enhancing diagnostic capabilities. Furthermore, favorable regulatory conditions, such as reimbursement schemes, further stimulate market growth. With these dynamics at play, the APAC organ transplant diagnostics market is poised for notable expansion, catering to the growing demand for effective diagnostic solutions in organ transplantation procedures across the region.

Market Segmentation:

Segmentation 1: by Country

  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Singapore
  • Rest-of-Asia-Pacific

How can this report add value to an organization?

Growth/Marketing Strategy: The APAC organ transplant diagnostics market has witnessed major development by key players operating in the market, such as product launches, business expansions, partnerships, collaborations, mergers and acquisitions, funding activities, and regulatory and legal approvals. The favored strategy for the companies has been synergistic activities such as partnerships, collaborations, expansions, and funding activities.

Competitive Strategy: The key players in the APAC organ transplant diagnostics market analyzed and profiled in the study involve established and emerging players that offer different products and services for organ transplant diagnostics. Moreover, a detailed competitive benchmarking of the players operating in the APAC organ transplant diagnostics market has been done to help the reader understand the ways in which players stack against each other, presenting a clear market landscape. Moreover, comprehensive competitive strategies such as partnerships, agreements, collaborations, and mergers and acquisitions will help the reader understand the untapped revenue pockets in the market.

Table of Contents

Executive Summary

1 Market Scope

  • 1.1 Key Questions Answered in the Report:

2 Research Methodology

  • 2.1 Organ Transplant Diagnostics Market: Research Methodology
  • 2.2 Data Sources
    • 2.2.1 Primary Data Sources
    • 2.2.2 Secondary Data Sources
  • 2.3 Market Estimation Model
  • 2.4 Criteria for Company Profiling

3 Organ Transplant Diagnostics Market: Overview

  • 3.1 Current Market Scenario
    • 3.1.1 For Researchers
    • 3.1.2 For Diagnostics
  • 3.2 Market Footprint
  • 3.3 COVID-19 Impact on Market
    • 3.3.1 Impact on Operations
    • 3.3.2 COVID-19 Impact: Current Scenario of Market
    • 3.3.3 Pre- and Post-COVID-19 Impact Assessment
      • 3.3.3.1 Pre-COVID-19 Phase
      • 3.3.3.2 Post-COVID-19 Phase

4 Organ Transplant Diagnostics Market: Industry Analysis

  • 4.1 Overview
  • 4.2 Legal Requirements and Framework in Asia-Pacific
    • 4.2.1 China
    • 4.2.2 Japan
  • 4.3 Reimbursement Scenario
  • 4.4 Patent Analysis
    • 4.4.1 Patent Filing Trend (by Country)
    • 4.4.2 Patent Filing Trend (by Year)

5 Organ Transplant Diagnostics Market: Market Dynamics

  • 5.1 Impact Analysis
  • 5.2 Market Drivers
    • 5.2.1 Rise in Incidence of Chronic Diseases Leading to Organ Failure Increases the Use of Transplant Diagnostics
    • 5.2.2 Increase in Adoption of Stem Cell Therapy and Incidences of Leukemia Leading to an Upsurge in Demand for Transplant Diagnostics Tests
    • 5.2.3 Presence of Favorable Regulatory Scenarios including Reimbursement Schemes for Some Organ Transplant Diagnostics
    • 5.2.4 Advantages of Developing Advanced Molecular and Genomic Technologies in Transplant Diagnostics Tests
  • 5.3 Market Restraints
    • 5.3.1 Increased Gap in Organ Donation and Organ Transplant Demand Hinders the Growth of Organ Transplant Diagnostics Market
    • 5.3.2 High Cost of Investment for Transplant Diagnostics Tests Acts as a Barrier to Growth of the Market
  • 5.4 Market Opportunities
    • 5.4.1 Development of Non-Invasive Techniques for Monitoring Transplant Recipients using NGS
    • 5.4.2 Advancements in Human Leukocyte Antigen (HLA) Typing Tests for Organ Transplant

6 Region

  • 6.1 Asia-Pacific
    • 6.1.1 Asia-Pacific Organ Transplant Test Volume, by Transplant Type
    • 6.1.2 Market Sizing and Forecast
      • 6.1.2.1 Asia-Pacific Organ Transplant Diagnostics Market (by Country)
        • 6.1.2.1.1 China
        • 6.1.2.1.2 India
        • 6.1.2.1.3 South Korea
        • 6.1.2.1.4 Japan
        • 6.1.2.1.5 Australia
        • 6.1.2.1.6 Singapore
        • 6.1.2.1.7 Rest-of-Asia-Pacific

7 Company Profiles

  • 7.1 Overview
  • 7.2 Manufacturers

List of Figures

  • Figure 1: Asia-Pacific Organ Transplant Diagnostics Market, $Billion, 2022-2033
  • Figure 2: Organ Transplant Diagnostics Market, Impact Analysis
  • Figure 3: Asia-Pacific Organ Transplant Diagnostics Market (by Offering), Share (%), 2022 and 2033
  • Figure 4: Asia-Pacific Organ Transplant Diagnostics Market (by Transplant Type), Share (%), 2022 and 2033
  • Figure 5: Asia-Pacific Organ Transplant Diagnostics Market (by Application), Share (%), 2022 and 2033
  • Figure 6: Asia-Pacific Organ Transplant Diagnostics Market (by Technology), Share (%), 2022 and 2033
  • Figure 7: Asia-Pacific Organ Transplant Diagnostics Market (by End User), Share (%), 2022 and 2033
  • Figure 8: Organ Transplant Diagnostics Market: Research Methodology
  • Figure 9: Primary Research Methodology
  • Figure 10: Bottom-Up Approach (Segment-Wise Analysis)
  • Figure 11: Top-Down Approach (Segment-Wise Analysis)
  • Figure 12: Organ Transplant Diagnostics Market, $Billion, 2022-2033
  • Figure 13: Organ Transplant Diagnostics Market, Patent Analysis (by Country), January 2018-December 2022
  • Figure 14: Organ Transplant Diagnostics Market, Patent Analysis (by Year), January 2018-December 2022
  • Figure 15: Organ Transplant Diagnostics Market, Impact Analysis
  • Figure 16: New Liver Cirrhosis and Other Chronic Liver Diseases Cases, Thousand, 2017 and 2021
  • Figure 17: Number of Solid Organ Transplants, 2017-2021
  • Figure 18: Applications of Stem Cell Therapy
  • Figure 19: Number of Transplants Performed and Patients on the Waiting List (by Organ), 2022
  • Figure 20: Organ Transplant Diagnostics Market Share and CAGR (by Region), 2022 and 2023-2033
  • Figure 21: Asia-Pacific Organ Transplant Diagnostics Market, $Billion, 2022-2033
  • Figure 22: Asia-Pacific Organ Transplant Diagnostics Market (by Country), Share (%), 2022 and 2033
  • Figure 23: China Organ Transplant Diagnostics Market, $Million, 2022-2033
  • Figure 24: India Organ Transplant Diagnostics Market, $Million, 2022-2033
  • Figure 25: South Korea Organ Transplant Diagnostics Market, $Million, 2022-2033
  • Figure 26: Japan Organ Transplant Diagnostics Market, $Million, 2022-2033
  • Figure 27: Australia Organ Transplant Diagnostics Market, $Million, 2022-2033
  • Figure 28: Singapore Organ Transplant Diagnostics Market, $Million, 2022-2033
  • Figure 29: Rest-of-Asia-Pacific Organ Transplant Diagnostics Market, $Million, 2022-2033
  • Figure 30: Total Number of Companies Profiled
  • Figure 31: Organ Transplant Diagnostics Market Overview, Key Companies

List of Tables

  • Table 1: Key Questions Answered in the Report
  • Table 2: Key Coverage Providers for Organ Transplant Diagnostics Tests
  • Table 3: Asia-Pacific Organ Transplant Diagnostics Market, Impact Analysis
  • Table 4: Asia-Pacific Organ Transplant Test Volume, by Transplant Type, 2021